Arcturus Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021Business Wire • 07/26/21
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal TherapeuticsPRNewsWire • 06/02/21
Arcturus Therapeutics Holdings' (ARCT) CEO Joseph Payne on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical DataBusiness Wire • 05/10/21
Arcturus Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 10, 2021Business Wire • 05/03/21
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/02/21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical UpdatesBusiness Wire • 03/01/21
Earnings Preview: Arcturus Therapeutics (ARCT) Q4 Earnings Expected to DeclineZacks Investment Research • 02/22/21
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021Business Wire • 02/19/21
Arcturus Therapeutics, Chesapeake Energy, Square, and More Wednesday Afternoon Analyst Calls24/7 Wall Street • 02/17/21
Arcturus Therapeutics Is A Worthwhile Bet As The Next Blockbuster COVID-19 Vaccine PlaySeeking Alpha • 01/26/21
McDonald's, Qualcomm, Starbucks, Tesla and More Tuesday Afternoon Analyst Calls24/7 Wall Street • 01/19/21
Domino's, FedEx, Lockheed, Roku and More of Tuesday Afternoon's Analyst Calls24/7 Wall Street • 01/07/21